Evaluation of clove phytochemicals as potential antiviral drug candidates targeting SARS-CoV-2 Main protease: computational docking, molecular dynamics …

A Chandra Manivannan, A Malaisamy… - Frontiers in Molecular …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can cause a
sudden respiratory disease spreading with a high mortality rate arising with unknown …

Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants

GA Gyebi, OB Ogunro, AP Adegunloye… - Journal of …, 2021 - Taylor & Francis
The novel coronavirus disease 2019 (COVID-19) caused by SARS-COV-2 has raised
myriad of global concerns. There is currently no FDA approved antiviral strategy to alleviate …

In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2

R Abdizadeh, F Hadizadeh, T Abdizadeh - Molecular Diversity, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by
SARS-CoV-2 that generated serious damages for both the human population and the global …

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study

MAA Ibrahim, EAR Mohamed… - Journal of Molecular …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a new pandemic characterized by quick
spreading and illness of the respiratory system. To date, there is no specific therapy for …

Potential of Plant Bioactive Compounds as SARS‐CoV‐2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study

TE Tallei, SG Tumilaar, NJ Niode, fnm Fatimawali… - …, 2020 - Wiley Online Library
Since the outbreak of the COVID‐19 (coronavirus disease 19) pandemic, researchers have
been trying to investigate several active compounds found in plants that have the potential to …

Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic

Z Fakhar, B Faramarzi, S Pacifico… - Journal of Biomolecular …, 2021 - Taylor & Francis
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …

Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual …

FM Abd El-Mordy, MM El-Hamouly, MT Ibrahim… - RSC …, 2020 - pubs.rsc.org
SARS-CoV-2 is a novel coronavirus that was first identified during the outbreak in Wuhan,
China in 2019. It is an acute respiratory illness that can transfer among human beings …

Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS …

S Houchi, Z Messasma - Journal of Molecular Structure, 2022 - Elsevier
Abstract The B. 1.617. 2 Delta variant is considered to be the most infectious of all SARS-
CoV2 variants. Here, an attempt has been made through in-silico screening of 55 bioactive …

Identification of potential bioactive natural compounds from Indonesian medicinal plants against 3-chymotrypsin-like protease (3CLpro) of SARS-CoV-2: molecular …

WE Prasetyo, H Purnomo, M Sadrini… - Journal of …, 2023 - Taylor & Francis
An outbreak of SARS-CoV-2 (COVID-19) has caused a global health emergency, resulting
in hundreds of millions of infections and millions of deaths globally since December 2019 …

[HTML][HTML] In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro …

A Boufissiou, M Abdalla, M Sharaf… - Journal of Saudi …, 2022 - Elsevier
There is currently a global COVID-19 pandemic caused by the severe acute respiratory
syndrome Coronavirus-2 (SARS-CoV-2) and its variants. This highly contagious viral …